3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
September 12, 2013 — Abbott promised preliminary results from a study presented at the ESC Congress 2013, suggesting ...
September 12, 2013
August 2, 2013 — Abbott announced results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay. The study ...
August 02, 2013
Feature | Kamran Zamanian, Ph.D., and Jefferson Harding, B.Sc., MA
Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters were the first devices used in the field of ...
July 23, 2013
July 18, 2013 — Abbott announced that it has entered into an agreement to purchase IDEV Technologies, a privately held ...
July 18, 2013
July 12, 2013 — Virginia Anderer, a Chicago native living in southern California, was the first patient in San Diego and ...
July 12, 2013
June 13, 2013 — Abbott announced publication of positive outcomes from two European post-approval studies of the ...
June 13, 2013
Feature | Kamran Zamanian, Ph.D., and Jefferson Harding, B.Sc., MA
Interventional cardiology treats cardiovascular disease, an illness currently afflicting one in every three Americans ...
May 30, 2013
May 28, 2013 — Abbott announced CE mark in Europe for the Xience Xpedition 48 Everolimus Eluting Coronary Stent System ...
May 28, 2013
April 18, 2013 — Abbott has received Conformite Europeene (CE) marking for the Architect Galectin-3 assay, a blood test ...
April 18, 2013
March 22, 2013 — Abbott announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of ...
March 22, 2013